Pathological features of inflammatory myopathy as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation

Neuropathology. 2022 Aug;42(4):309-314. doi: 10.1111/neup.12816. Epub 2022 May 4.

Abstract

Chronic graft-versus-host disease (cGVHD) is the most important complication resulting in the death of bone marrow transplantation (BMT) survivors. It is also a relatively rare cause of inflammatory myopathy (IM). We report the case of a 46-year-old woman who developed severe cGVHD-related IM after BMT for myelodysplastic syndrome. She presented with severe muscle pain and weakness with cGVHD-related symptoms in other organs. Myopathological analysis showed moderate cell infiltration with remarkable necrotic and regenerative fibers. Sarcoplasm and capillaries expressed C5b9 and myxovirus resistance protein 1. Non-necrotic fibers in perifascicular regions expressed MHC-II. Steroid therapy did not sufficiently control cGVHD-related IM, and the patient was concurrently treated with an immunosuppressant. Our findings show that IM is a key manifestation of cGVHD and that the expression of interferon-inducible proteins in muscle pathology is useful for identifying cGVHD-related IM.

Keywords: bone marrow transplantation (BMT); graft-versus-host disease (GVHD); inflammatory myopathy (IM); myelodysplastic syndrome (MDS); myxovirus resistance protein 1 (MxA).

Publication types

  • Case Reports

MeSH terms

  • Bone Marrow Transplantation / adverse effects
  • Chronic Disease
  • Female
  • Graft vs Host Disease* / complications
  • Graft vs Host Disease* / pathology
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Middle Aged
  • Myositis* / complications